Form 4 for TAK TAKEDA PHARMACEUTICAL CO LTD
Accepted 2026-09-15 21:12:46 ET · period of report 2026-09-14 · accession 0001395064-26-000340 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 21:12 | 2026-09-14 | TAK | Duprey Lauren Rusckowski | Chief Transformation Off | S - Sale | $18.54 | -34.5K | 191.5K | -15% | -$640.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2026-09-14 | S | D | 34,535 | $18.54 | 191,522 | D | — | — |